NCT00437242View on ClinicalTrials.gov

Odiparcil QT Definitive Study

PHASE1TerminatedINTERVENTIONAL

Enrollment

54

Participants

Timeline

Start Date

October 31, 2006

Conditions

Fibrillation, AtrialAtrial Fibrillation

Interventions

DRUG

Odiparcil

Trial Locations (1)

78744

GSK Investigational Site, Austin

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00437242 - Odiparcil QT Definitive Study | Biotech Hunter | Biotech Hunter